Why Is Germany Buying $3.5 Billion Worth of RTX Missiles?

Germany has asked the U.S. DSCA to approve a $3.5 billion purchase from RTX for 173 SM-6 Block I and up to 577 SM-2 Block IIIC missiles plus MK 21/MK 13 vertical launch systems, with RTX named principal contractor and Congressional approval likely; Germany plans to deploy the systems on F127-class frigates. Public unit-cost estimates (SM-2 ≈ $2m, SM-6 $4–5m) imply a U.S.-buyer-equivalent value of roughly $2 billion, so the reported price appears unusually rich and should be highly accretive to RTX—using recent Raytheon margins a $3.5 billion sale implies roughly $350m of operating profit (~$0.26/share) and, under higher margins, perhaps up to ~$0.45/share pre-tax—though revenues and profit will likely be recognized over several years. While the transaction should improve RTX’s defense-margin profile and earnings modestly, it is unlikely on its own to meaningfully change the investment thesis for a large-cap defense company trading at ~35x earnings with modest dividend expectations.

Analysis

Germany has formally requested U.S. DSCA approval to purchase $3.5 billion of missile inventory from RTX, comprising 173 SM-6 Block I missiles, up to 577 SM-2 Block IIIC missiles and multiple MK 21/MK 13 vertical launch systems, with RTX named principal contractor and Congressional approval historically likely. Public unit-cost estimates in the article put SM-2 at roughly $2 million each and SM-6 at $4–$5 million each, implying a U.S.-buyer-equivalent value near $2 billion versus the $3.5 billion contract price, so the deal appears unusually premium-priced. RTX’s Raytheon division generated $26.7 billion of revenue and $2.6 billion of operating profit last year (≈10% operating margin); on that basis a $3.5 billion sale implies about $350 million of operating profit (~$0.26/share) and, under higher margins, up to roughly $0.45/share pre-tax. The article notes recognition will likely be multi-year (possibly up to a decade), so while the transaction is margin-accretive and supportive to earnings, it is unlikely by itself to materially change RTX’s investment case given its large scale, current ~35x P/E, 1.6% dividend yield and analyst expectations of ~10% annual EPS growth.

Key Decisions for Investors

• Treat the sale as accretive but incremental: expect roughly $0.26–$0.45 per share pre-tax spread over multiple years rather than a near-term earnings catalyst, so avoid aggressive re-rating of RTX based solely on this contract
• Monitor delivery and revenue recognition schedules, gross margin realization on the international pricing premium, and any disclosures from RTX on contract timing before increasing exposure
• Given RTX’s valuation (~35x earnings) and modest dividend, consider maintaining or modestly trimming positions on any post-approval share pop and redeploying proceeds into higher-conviction ideas unless sustained margin improvement is evident